GETI.B

191.85

+0.1%↑

VITR

155.4

-0.7%↓

AMBEA

106.2

-2.48%↓

ARJOB

31.24

-0.19%↓

MSON.B

8.74

-1.13%↓

GETI.B

191.85

+0.1%↑

VITR

155.4

-0.7%↓

AMBEA

106.2

-2.48%↓

ARJOB

31.24

-0.19%↓

MSON.B

8.74

-1.13%↓

GETI.B

191.85

+0.1%↑

VITR

155.4

-0.7%↓

AMBEA

106.2

-2.48%↓

ARJOB

31.24

-0.19%↓

MSON.B

8.74

-1.13%↓

GETI.B

191.85

+0.1%↑

VITR

155.4

-0.7%↓

AMBEA

106.2

-2.48%↓

ARJOB

31.24

-0.19%↓

MSON.B

8.74

-1.13%↓

GETI.B

191.85

+0.1%↑

VITR

155.4

-0.7%↓

AMBEA

106.2

-2.48%↓

ARJOB

31.24

-0.19%↓

MSON.B

8.74

-1.13%↓

Начало・Списък с акции・RaySearch Laboratories AB

R
RaySearch Laboratories AB

Затворен

314 0.16

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

311

Максимум

326.5

Ключови измерители
By Trading Economics
Приходи	-21M 57M
Продажби	29M 323M
P/E Средно за сектора	52.357 56.602
EPS	1.75
Дивидентна доходност	1.25
Марж на печалбата	17.606
Служители	416
EBITDA	12M 74M

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	1.25% 2.45%

Пазарни показатели
By TradingEconomics
Пазарна капитализация	1.9B 11B
Предишно отваряне	313.84
Предишно затваряне	314

RaySearch Laboratories AB Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.05.2025 г., 23:40 ч. UTC

Горещи акции

Stocks to Watch: UnitedHealth Group, Foot Locker, CoreWeave

14.05.2025 г., 23:33 ч. UTC

Значими двигатели на пазара

UnitedHealth Group Shares Fall After WSJ Reports of Investigation for Possible Medicare Fraud

14.05.2025 г., 23:25 ч. UTC

Значими двигатели на пазара

Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole

14.05.2025 г., 23:25 ч. UTC

Печалби

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth -- Update

14.05.2025 г., 22:58 ч. UTC

Печалби

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth

14.05.2025 г., 21:35 ч. UTC

Печалби

Cisco Systems Names Patterson as CFO, Patel as President

14.05.2025 г., 23:59 ч. UTC

Пазарно говорене

Implications of Xero's Cost Outlook Aren't Clear -- Market Talk

14.05.2025 г., 23:49 ч. UTC

Пазарно говорене

Xero's Cost Outlook Likely to Prompt Downgrades -- Market Talk

14.05.2025 г., 23:48 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

14.05.2025 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Decline on Profit-Taking After Recent Gains -- Market Talk

14.05.2025 г., 23:47 ч. UTC

Пазарно говорене

Gold Gains on Possible Technical Recovery -- Market Talk

14.05.2025 г., 23:34 ч. UTC

Придобивния, сливания и поглъщания

Agnico-Eagle Mines to Subscribe for 30M Voting Common Shares of Foran Mining in Non-Brokered Private Placement at C$3 a Share

14.05.2025 г., 23:10 ч. UTC

Печалби

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth -- Update

14.05.2025 г., 23:07 ч. UTC

Печалби

CoreWeave Posts Strong Revenue and Wins Google as a Customer. Stock Still Dives on Outlook. -- Barrons.com

14.05.2025 г., 23:00 ч. UTC

Топ новини

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud -- WSJ

14.05.2025 г., 22:43 ч. UTC

Печалби

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth

14.05.2025 г., 22:34 ч. UTC

Печалби

Xero Expects 1H Operating Expense Ratio to Be Higher Than 2H>XRO.AU

14.05.2025 г., 22:33 ч. UTC

Печалби

Xero Expects FY26 Operating Expense Ratio of 71.5%>XRO.AU

14.05.2025 г., 22:30 ч. UTC

Печалби

Xero Did Not Declare a Dividend>XRO.AU

14.05.2025 г., 22:30 ч. UTC

Печалби

Xero FY Operating Expenses 71.8% of Operating Revenue Vs. 73.3%>XRO.AU

14.05.2025 г., 22:30 ч. UTC

Печалби

Xero FY Free Cashflow Margin 24.1% Vs. 20.0%>XRO.AU

14.05.2025 г., 22:30 ч. UTC

Печалби

Xero FY Free Cashflow NZD506.7M Vs. NZD342.1M>XRO.AU

14.05.2025 г., 22:28 ч. UTC

Печалби

Xero FY Ebitda NZD638.5M Vs. NZD497.4M>XRO.AU

14.05.2025 г., 22:28 ч. UTC

Печалби

Xero FY Adjusted Ebitda NZD640.6M Vs. NZD526.5M>XRO.AU

14.05.2025 г., 22:27 ч. UTC

Печалби

Xero FY Rev NZD2.10B Vs. NZD1.71B >XRO.AU

14.05.2025 г., 22:27 ч. UTC

Печалби

Xero FY Net NZD227.8M Vs. Net NZD174.6M >XRO.AU

14.05.2025 г., 22:23 ч. UTC

Топ новини

Boeing, GE Aerospace Get Qatar Airways Order After Saudi AI Tech Deals -- 2nd Update

14.05.2025 г., 22:15 ч. UTC

Печалби

Correction to Cisco Earnings Article -- WSJ

14.05.2025 г., 21:48 ч. UTC

Печалби

CoreWeave Posts Strong Revenue but Stock Dives on Updated Outlook -- Barrons.com

14.05.2025 г., 21:37 ч. UTC

Печалби

Cisco Reports Solid Earnings. The Stock Is Rising. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

RaySearch Laboratories AB Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) is headquartered in Stockholm, Sweden.